{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T04:37:01Z","timestamp":1722832621974},"reference-count":62,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T00:00:00Z","timestamp":1365120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Psychopharmacology"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Overactivity of dopaminergic neurotransmission is a putative mechanism of tardive dyskinesia (TD). Dopamine beta\u2010hydroxylase (DBH) is a key enzyme in the conversion of dopamine to norepinephrine, and plasma DBH activity is altered in TD patients. This study examined whether the functional DBH 5'\u2010Ins\/Del polymorphism was associated with TD severity in Chinese patients with schizophrenia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We compared the rate of this polymorphism in patients with (<jats:italic>n<\/jats:italic>\u2009=\u2009312) and without TD (<jats:italic>n<\/jats:italic>\u2009=\u2009435), and healthy controls (<jats:italic>n<\/jats:italic>\u2009=\u2009625). The severity of TD was assessed using the Abnormal Involuntary Movement Scale (AIMS) and psychopathology using the Positive and Negative Syndrome Scale (PANSS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were no significant differences in the distribution of the allele and genotype frequencies between the patients and controls, or between the patients with and without TD. Also, there was no significant difference in the AIMS total score between the three genotype groups. However, the PANSS positive symptom subscore was significantly higher in patients with Del\/Del genotype (13.2\u2009\u00b1\u20095.2) than those with Ins\/Del (11.2\u2009\u00b1\u20094.9) and Ins\/Ins (11.1\u2009\u00b1\u20093.1) genotypes (both <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These results suggest that although the DBH 5'\u2010Ins\/Del polymorphism was not associated with susceptibility to TD in patients with schizophrenia, it might be related to positive symptoms of schizophrenia. Copyright \u00a9 2013 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/hup.2311","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T09:32:09Z","timestamp":1365154329000},"page":"230-237","source":"Crossref","is-referenced-by-count":13,"title":["Association of the dopamine \u03b2\u2010hydroxylase 19\u2009bp insertion\/deletion polymorphism with positive symptoms but not tardive dyskinesia in schizophrenia"],"prefix":"10.1002","volume":"28","author":[{"given":"Na","family":"Zhou","sequence":"first","affiliation":[{"name":"School of Basic Medicine Jilin University  Changchun China"},{"name":"School of Stomatology Jilin University  Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Yu","sequence":"additional","affiliation":[{"name":"Center of Medical Genomics, School of Public Health Jilin University  Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[{"name":"School of Basic Medicine Jilin University  Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqin","family":"Yu","sequence":"additional","affiliation":[{"name":"Center of Medical Genomics, School of Public Health Jilin University  Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgui","family":"Kou","sequence":"additional","affiliation":[{"name":"Center of Medical Genomics, School of Public Health Jilin University  Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Li","sequence":"additional","affiliation":[{"name":"Center of Medical Genomics, School of Public Health Jilin University  Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqin","family":"Xu","sequence":"additional","affiliation":[{"name":"Center of Medical Genomics, School of Public Health Jilin University  Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingguang","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Yale University School of Medicine  New Haven CT USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjun","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Yale University School of Medicine  New Haven CT USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[{"name":"Menninger Department of Psychiatry and Behavioral Sciences Baylor College of Medicine, and Michael E. DeBakey VA Medical Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Menninger Department of Psychiatry and Behavioral Sciences Baylor College of Medicine, and Michael E. DeBakey VA Medical Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,5]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.08.036"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(20000207)96:1<88::AID-AJMG18>3.0.CO;2-V"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4002142"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200004000-00011"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000847"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(97)82574-6"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.41.1.237"},{"issue":"4","key":"e_1_2_7_9_1","first-page":"5","article-title":"Tardive dyskinesia: pathophysiology and animal models","volume":"61","author":"Casey DE","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-1949-9"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e3282f53132"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19970725)74:4<374::AID-AJMG7>3.0.CO;2-P"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004390050736"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000657"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.11.1474"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/10401230209147398"},{"issue":"4","key":"e_1_2_7_17_1","first-page":"21","article-title":"Expected incidence of tardive dyskinesia associated with atypical antipsychotics","volume":"61","author":"Glazer WM","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(87)90053-9"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23377"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0054"},{"issue":"9","key":"e_1_2_7_21_1","first-page":"21","article-title":"Tardive dyskinesia rates with atypical antipsychotics in older adults","volume":"65","author":"Jeste DV","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_22_1","first-page":"75","article-title":"Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia","volume":"42","author":"Jeste DV","year":"1981","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00041444-200309000-00007"},{"issue":"9","key":"e_1_2_7_24_1","first-page":"16","article-title":"Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence","volume":"65","author":"Kane JM","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(86)90245-3"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.0.CO;2-W"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000103576"},{"issue":"1","key":"e_1_2_7_28_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.31887\/DCNS.2006.8.1\/blerer","article-title":"Pharmacogenetics of antipsychotic therapy: pivotal research issues and the prospects for clinical implementation","volume":"8","author":"Lerer B","year":"2006","journal-title":"Dialogues Clin Neurosci"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(02)00293-2"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200317010-00004"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2012.0005"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370505001110"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-7672"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00041444-199621000-00004"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/10673220902979896"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2001.00401.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0860149"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2006.10.005"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145704004419"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30516"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbi036"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(91)90339-G"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.11.015"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/00041444-199722000-00002"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(94)90085-X"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290040080014"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(99)00021-3"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/22.4.597"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2009.220"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2011.36"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201838"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20823"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30981"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198210000-00005"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0920-9964(96)00064-3"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/00041444-199800810-00003"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19991015)88:5<557::AID-AJMG22>3.0.CO;2-F"},{"key":"e_1_2_7_58_1","first-page":"160","article-title":"Linkage of a gene regulating dopamine\u2010beta\u2010hydroxylase activity and the ABO blood group locus","volume":"42","author":"Wilson AF","year":"1988","journal-title":"Am J Hum Genet"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.10011"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1987.tb02754.x"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2009.09.020"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1590-8"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0139"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.2311","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.2311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:36:01Z","timestamp":1700624161000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.2311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,5]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1002\/hup.2311"],"URL":"https:\/\/doi.org\/10.1002\/hup.2311","archive":["Portico"],"relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"value":"0885-6222","type":"print"},{"value":"1099-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,5]]}}}